Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

Inclusion Criteria: 1. Healthy males, 20 to 45 years of age the moment of screening 2. Body mass index is between 19.0 and 27.0 kg/m2 Exclusion Criteria: 1. Hypersensitivity response to the experimental and comparator drugs 2. The tuberculosis patient or latent tuberculosis patient